Before Kanna became a name on supplement labels, it was a South African plant with a history rooted in Indigenous knowledge. That's the starting point worth keeping in view, even when you're meeting it through a modern gummy or tablet.
Sceletium tortuosum, commonly called Kanna, is a succulent. Published research describes its traditional use by San and Khoikhoi people and later use by European colonial farmers. Today's commercial extracts are part of its modern history, not a replacement for the people and knowledge that came first.
Meet the plant behind the name
Kanna belongs to a group of plants known for their succulent growth. Its botanical identity matters because common names can travel faster than accurate information. When you're looking at a product, the name Sceletium tortuosum gives you a more specific starting point than a broad phrase such as “botanical blend.”
It isn't cannabis, kava, or kratom. Those names refer to different plants with different chemical constituents. Similar marketing language doesn't make them interchangeable.
The botanical name also doesn't tell you everything in a finished supplement. It identifies the source plant, not the full recipe, concentration, or manufacturing process.
Give the roots their proper credit
The 2013 research paper by Terburg and colleagues places Kanna's traditional use within San and Khoikhoi history. It describes the plant as a masticatory, meaning material chewed, and as part of traditional medicine. The paper also notes later use by colonial farmers in tincture form.
That is a historical account, not a set of instructions for preparing or consuming the plant today. Traditional practices developed within particular communities and contexts. Condensing them into a modern wellness slogan can remove the very context that makes the history meaningful.
It's also important not to treat San and Khoikhoi people as a single, interchangeable group. Naming communities specifically is more respectful than describing the plant as an anonymous “ancient discovery.” The story doesn't begin when outside researchers or businesses become interested.
History isn't a clinical trial
A long record of traditional use can help researchers decide which plants deserve study. It cannot answer every modern question about safety, interactions, or the experience of a concentrated commercial extract.
Researchers need to examine the particular material being tested, who receives it, how outcomes are measured, and what unwanted effects occur. Those questions remain relevant even when a plant has a well-documented cultural history.
The difference is practical. “People have used this plant for generations” and “this specific product has been evaluated in a controlled study” are two different statements. A product page shouldn't quietly swap one for the other.
From plant material to extract
Modern research frequently concerns a standardized extract called Zembrin. In the published studies cited below, researchers characterized its alkaloid composition and tested it under controlled conditions. That makes their findings more specific, not more universal.
A whole plant preparation and a selected extract may differ in composition. Finished tablets and gummies can add other ingredients on top of that difference. The shared word “Kanna” doesn't prove that they're equivalent to a traditional preparation or a research extract.
For a closer look at those constituents, read Kanna's alkaloids explained. For the shopping side of the story, our format guide separates what's in a product from how it's presented.
What modern research adds
One small brain-imaging study enrolled 16 healthy participants and measured responses to emotional faces after a particular extract. Another pilot study enrolled 21 healthy middle-aged adults and examined cognitive test performance. These studies are useful examples of how researchers move from interest in a plant to questions they can test.
They don't recreate the full context of traditional use. They also don't establish the effects of every modern Kanna product or a treatment for a medical condition. Historical knowledge and clinical evidence can inform different parts of the conversation without being mistaken for each other.
A better way to read a plant's story
Look for clear attribution. Which communities are named? Is the botanical source identified? Does the discussion distinguish historical use from current research? Are claims about sourcing supported rather than decorated with vague language?
A South African origin story doesn't tell you where a particular brand grows or buys its ingredients. Cultivation, sourcing relationships, and environmental practices require their own evidence. Those details shouldn't be assumed from the plant's native range.
You can enjoy learning about Kanna without turning its history into a promise. The most useful introduction keeps the plant, its cultural roots, and the modern product clearly in focus.
Common questions
Did Kanna begin as a modern supplement?
No. Published accounts describe traditional use by San and Khoikhoi communities before today's commercial supplement formats.
Does traditional use prove a modern extract is safe?
No. Its composition, formulation, individual risks, and interactions still need consideration.
Does the plant's origin establish a brand's sourcing?
No. A brand's cultivation and sourcing claims require product-specific information.
References
- Terburg et al. (2013). Acute Effects of Sceletium tortuosum (Zembrin), a Dual 5-HT Reuptake and PDE4 Inhibitor, in the Human Amygdala and its Connection to the Hypothalamus.
- Chiu et al. (2014). Proof-of-Concept Randomized Controlled Study of Cognition Effects of the Proprietary Extract Sceletium tortuosum (Zembrin) Targeting Phosphodiesterase-4 in Cognitively Healthy Subjects.
